HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An epidemic of fatal 3-methylfentanyl poisoning in Estonia.

Abstract
An exceptional epidemic of poisonings due to the highly potent opioid designer drug 3-methylfentanyl (TMF) was revealed among Estonian drug users in 2005-2006 by post-mortem forensic toxicology. Quantitative analysis of cis-TMF, trans-TMF, and fentanyl was performed by liquid chromatography-tandem mass spectrometry. Comprehensive toxicological analysis was performed using a multi-technique approach. The number of TMF-related fatal accidental poisonings identified was 46 and 71 for 2005 and 2006, respectively. The proportion of male victims was 91.5% and the mean age of all victims was 26 years at death. TMF was used predominantly by intravenous injection. There was no significant difference in the blood concentrations of cis-TMF and trans-TMF between pure TMF poisonings and mixed TMF poisonings. The mean combined concentration of TMF stereoisomers among pure TMF cases (1.9 microg/l) was more than ten times lower than the mean fentanyl concentration in fentanyl-related fatalities. Concomitant use of other drugs involved alcohol, amphetamines, benzodiazepines, and cannabis, but very rarely other opioids.
AuthorsIlkka Ojanperä, Merja Gergov, Milana Liiv, Aime Riikoja, Erkki Vuori
JournalInternational journal of legal medicine (Int J Legal Med) Vol. 122 Issue 5 Pg. 395-400 (Sep 2008) ISSN: 0937-9827 [Print] Germany
PMID18386033 (Publication Type: Journal Article)
Chemical References
  • Analgesics
  • 3-methylfentanyl
  • Fentanyl
Topics
  • Adult
  • Analgesics (analysis, chemistry, poisoning)
  • Chromatography, Liquid
  • Disease Outbreaks
  • Estonia (epidemiology)
  • Female
  • Fentanyl (analogs & derivatives, analysis, chemistry, poisoning)
  • Forensic Toxicology
  • Humans
  • Male
  • Molecular Structure
  • Poisoning (epidemiology)
  • Sex Distribution
  • Stereoisomerism
  • Substance-Related Disorders (epidemiology)
  • Tandem Mass Spectrometry

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: